007570 — Ilyang Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩234bn
- KR₩341bn
- KR₩371bn
- 52
- 44
- 40
- 40
Annual cashflow statement for Ilyang Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 19,595 | 21,545 | 25,956 | 31,741 | 112 |
| Depreciation | |||||
| Non-Cash Items | 19,255 | 11,909 | 19,730 | 12,168 | 24,135 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12,747 | 11,366 | 8,684 | -27,037 | -18,469 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 36,193 | 57,484 | 67,020 | 29,936 | 19,382 |
| Capital Expenditures | -8,385 | -24,622 | -21,352 | -20,535 | -12,005 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 7,170 | 3,462 | 8.24 | 28,121 | -50,603 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,215 | -21,160 | -21,344 | 7,585 | -62,608 |
| Financing Cash Flow Items | 34.5 | -142 | -31,524 | 184 | -22 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -21,654 | -30,961 | -43,127 | -23,396 | -6,960 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13,689 | 5,446 | 6,390 | 11,865 | -50,112 |